⌘K
| Date | TitleTitle | |||
|---|---|---|---|---|
| 01/07/25 | 07:00:05 | 1 Jul 2025 | Total Voting Rights | |
| 23/06/25 | 07:00:09 | 23 Jun 2025 | OXB completes acquisition of US subsidiary | |
| 17/06/25 | 18:00:32 | 17 Jun 2025 | Director/PDMR Shareholding | |
| 11/06/25 | 18:02:59 | 11 Jun 2025 | Result of Annual General Meeting | |
| 11/06/25 | 07:02:28 | 11 Jun 2025 | AGM Update | |
| 10/06/25 | 10:49:08 | 10 Jun 2025 | Holding(s) in Company | |
| 05/06/25 | 07:00:15 | 5 Jun 2025 | Block Listing Application | |
| 03/06/25 | 07:00:11 | 3 Jun 2025 | OXB Launches Advisory Board | |
| 02/06/25 | 07:00:10 | 2 Jun 2025 | Total Voting Rights | |
| 16/05/25 | 17:52:05 | 16 May 2025 | Grant of options | |
| 01/05/25 | 07:00:06 | 1 May 2025 | Total Voting Rights | |
| 30/04/25 | 16:49:05 | 30 Apr 2025 | Person Closely Associated Dealing | |
| 29/04/25 | 18:14:44 | 29 Apr 2025 | Holding(s) in Company | |
| 28/04/25 | 13:00:01 | 28 Apr 2025 | 2025 Annual General Meeting notification | |
| 23/04/25 | 17:45:28 | 23 Apr 2025 | Holding(s) in Company | |
| 09/04/25 | 07:00:09 | 9 Apr 2025 | Preliminary results for the year ended 31 Dec 2024 | |
| 04/04/25 | 08:52:33 | 4 Apr 2025 | Holding(s) in Company | |
| 01/04/25 | 07:00:01 | 1 Apr 2025 | OXB Total Voting Rights | |
| 27/03/25 | 16:45:04 | 27 Mar 2025 | Director Declaration | |
| 03/03/25 | 09:00:00 | 3 Mar 2025 | Total Voting Rights | |
| 26/02/25 | 07:00:09 | 26 Feb 2025 | OXB to present at Leerink Conference | |
| 20/02/25 | 15:42:51 | 20 Feb 2025 | Holding(s) in Company | |
| 20/02/25 | 13:32:53 | 20 Feb 2025 | OXB Lentiviral Vectors Used in Gene Therapy Trial | |
| 20/02/25 | 13:13:47 | 20 Feb 2025 | Standard form for notification of major holdings | |
| 17/02/25 | 07:00:05 | 17 Feb 2025 | Full Year Trading Update and Notice of Results | |
| 05/02/25 | 07:00:07 | 5 Feb 2025 | Appointment of New Joint Corporate Broker | |
| 03/02/25 | 07:00:03 | 3 Feb 2025 | Total Voting Rights | |
| 23/01/25 | 11:07:06 | 23 Jan 2025 | Block Listing Application | |
| 16/01/25 | 16:23:47 | 16 Jan 2025 | Holding(s) in Company | |
| 16/01/25 | 16:20:23 | 16 Jan 2025 | Holding(s) in Company | |
| 15/01/25 | 16:30:27 | 15 Jan 2025 | Holding(s) in Company | |
| 02/01/25 | 07:00:07 | 2 Jan 2025 | Block Listing Return | |
| 02/01/25 | 07:00:06 | 2 Jan 2025 | Total Voting Rights | |
| 02/12/24 | 07:00:07 | 2 Dec 2024 | Total Voting Rights | |
| 22/11/24 | 14:56:45 | 22 Nov 2024 | Grant of options | |
| 18/11/24 | 07:00:05 | 18 Nov 2024 | Board Changes | |
| 15/11/24 | 07:00:06 | 15 Nov 2024 | OXB to present at Jefferies Healthcare Conference | |
| 05/11/24 | 14:23:59 | 5 Nov 2024 | Grant of options | |
| 04/11/24 | 10:56:59 | 4 Nov 2024 | Holding(s) in Company | |
| 01/11/24 | 07:00:02 | 1 Nov 2024 | Total Voting Rights | |
| 31/10/24 | 07:00:10 | 31 Oct 2024 | Holding(s) in Company | |
| 21/10/24 | 09:47:49 | 21 Oct 2024 | Block Listing Application | |
| 04/10/24 | 15:25:30 | 4 Oct 2024 | Grant of Options | |
| 03/10/24 | 16:05:13 | 3 Oct 2024 | Holding(s) in Company | |
| 01/10/24 | 17:33:11 | 1 Oct 2024 | Holding(s) in Company | |
| 01/10/24 | 07:00:04 | 1 Oct 2024 | Total Voting Rights | |
| 23/09/24 | 07:00:08 | 23 Sept 2024 | Interim Results | |
| 18/09/24 | 07:00:10 | 18 Sept 2024 | Oxford Biomedica rebrands as OXB | |
| 02/09/24 | 07:00:10 | 2 Sept 2024 | Lucinda Crabtree joins OXB as CFO today | |
| 02/09/24 | 07:00:09 | 2 Sept 2024 | Total Voting Rights |
| Date | TitleTitle | |||
|---|---|---|---|---|
| 01/07/25 | 07:00:05 | 1 Jul 2025 | Total Voting Rights | |
| 23/06/25 | 07:00:09 | 23 Jun 2025 | OXB completes acquisition of US subsidiary | |
| 17/06/25 | 18:00:32 | 17 Jun 2025 | Director/PDMR Shareholding | |
| 11/06/25 | 18:02:59 | 11 Jun 2025 | Result of Annual General Meeting | |
| 11/06/25 | 07:02:28 | 11 Jun 2025 | AGM Update | |
| 10/06/25 | 10:49:08 | 10 Jun 2025 | Holding(s) in Company | |
| 05/06/25 | 07:00:15 | 5 Jun 2025 | Block Listing Application | |
| 03/06/25 | 07:00:11 | 3 Jun 2025 | OXB Launches Advisory Board | |
| 02/06/25 | 07:00:10 | 2 Jun 2025 | Total Voting Rights | |
| 16/05/25 | 17:52:05 | 16 May 2025 | Grant of options | |
| 01/05/25 | 07:00:06 | 1 May 2025 | Total Voting Rights | |
| 30/04/25 | 16:49:05 | 30 Apr 2025 | Person Closely Associated Dealing | |
| 29/04/25 | 18:14:44 | 29 Apr 2025 | Holding(s) in Company | |
| 28/04/25 | 13:00:01 | 28 Apr 2025 | 2025 Annual General Meeting notification | |
| 23/04/25 | 17:45:28 | 23 Apr 2025 | Holding(s) in Company | |
| 09/04/25 | 07:00:09 | 9 Apr 2025 | Preliminary results for the year ended 31 Dec 2024 | |
| 04/04/25 | 08:52:33 | 4 Apr 2025 | Holding(s) in Company | |
| 01/04/25 | 07:00:01 | 1 Apr 2025 | OXB Total Voting Rights | |
| 27/03/25 | 16:45:04 | 27 Mar 2025 | Director Declaration | |
| 03/03/25 | 09:00:00 | 3 Mar 2025 | Total Voting Rights | |
| 26/02/25 | 07:00:09 | 26 Feb 2025 | OXB to present at Leerink Conference | |
| 20/02/25 | 15:42:51 | 20 Feb 2025 | Holding(s) in Company | |
| 20/02/25 | 13:32:53 | 20 Feb 2025 | OXB Lentiviral Vectors Used in Gene Therapy Trial | |
| 20/02/25 | 13:13:47 | 20 Feb 2025 | Standard form for notification of major holdings | |
| 17/02/25 | 07:00:05 | 17 Feb 2025 | Full Year Trading Update and Notice of Results | |
| 05/02/25 | 07:00:07 | 5 Feb 2025 | Appointment of New Joint Corporate Broker | |
| 03/02/25 | 07:00:03 | 3 Feb 2025 | Total Voting Rights | |
| 23/01/25 | 11:07:06 | 23 Jan 2025 | Block Listing Application | |
| 16/01/25 | 16:23:47 | 16 Jan 2025 | Holding(s) in Company | |
| 16/01/25 | 16:20:23 | 16 Jan 2025 | Holding(s) in Company | |
| 15/01/25 | 16:30:27 | 15 Jan 2025 | Holding(s) in Company | |
| 02/01/25 | 07:00:07 | 2 Jan 2025 | Block Listing Return | |
| 02/01/25 | 07:00:06 | 2 Jan 2025 | Total Voting Rights | |
| 02/12/24 | 07:00:07 | 2 Dec 2024 | Total Voting Rights | |
| 22/11/24 | 14:56:45 | 22 Nov 2024 | Grant of options | |
| 18/11/24 | 07:00:05 | 18 Nov 2024 | Board Changes | |
| 15/11/24 | 07:00:06 | 15 Nov 2024 | OXB to present at Jefferies Healthcare Conference | |
| 05/11/24 | 14:23:59 | 5 Nov 2024 | Grant of options | |
| 04/11/24 | 10:56:59 | 4 Nov 2024 | Holding(s) in Company | |
| 01/11/24 | 07:00:02 | 1 Nov 2024 | Total Voting Rights | |
| 31/10/24 | 07:00:10 | 31 Oct 2024 | Holding(s) in Company | |
| 21/10/24 | 09:47:49 | 21 Oct 2024 | Block Listing Application | |
| 04/10/24 | 15:25:30 | 4 Oct 2024 | Grant of Options | |
| 03/10/24 | 16:05:13 | 3 Oct 2024 | Holding(s) in Company | |
| 01/10/24 | 17:33:11 | 1 Oct 2024 | Holding(s) in Company | |
| 01/10/24 | 07:00:04 | 1 Oct 2024 | Total Voting Rights | |
| 23/09/24 | 07:00:08 | 23 Sept 2024 | Interim Results | |
| 18/09/24 | 07:00:10 | 18 Sept 2024 | Oxford Biomedica rebrands as OXB | |
| 02/09/24 | 07:00:10 | 2 Sept 2024 | Lucinda Crabtree joins OXB as CFO today | |
| 02/09/24 | 07:00:09 | 2 Sept 2024 | Total Voting Rights |
